Search

Search Constraints

You searched for: Author/Creator Yamada, Ryoko

Search Results

1. Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus–Infected Hepatocytes During Interferon Administration. Issue 2 (25th August 2021)

2. CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C. Issue 10 (25th September 2018)

4. Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment. Issue 5 (9th March 2021)

5. Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment. Issue 10 (3rd August 2020)

6. Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma. Issue 7 (25th April 2022)

7. Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongation. Issue 11 (10th July 2019)

8. Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis. Issue 4 (22nd December 2022)

9. Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all‐oral direct‐acting antivirals: Analysis of a Japanese prospective cohort. Issue 13 (1st August 2017)

10. Hepatocellular carcinoma due to a baffle obstruction after the mustard operation: A case report. Issue 6 (19th April 2018)